- Home
- SOLV
SOLV
SOLVENTUM CORP
as 11-15-2024 4:00pm EST
Stocks
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
| Founded: | 2023 | Country: | United States |
| Employees: | N/A | City: | ST. PAUL |
| Market Cap: | 12.6B | IPO Year: | N/A |
| Target Price: | $68.00 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Hold | Number of Analysts: | 9 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 4.16 | EPS Growth: | -47.94 |
| 52 Week Low/High: | $47.16 - $77.17 | Next Earning Date: | 11-26-2024 |
| Revenue: | $8,215,000,000 | Revenue Growth: | 0.60% |
| Revenue Growth (this year): | 2.17% | Revenue Growth (next year): | 0.30% |
Latest SOLVENTUM CORP News
SOLV Breaking Stock News: Dive into SOLV Ticker-Specific Updates for Smart Investing
PR Newswire
3 days ago
Solventum Launches First 3D Printed Aligner Attachments to Revolutionize Aligner Treatment
TipRanks
5 days ago
Solventum price target raised to $73 from $60 at Morgan Stanley
Simply Wall St.
7 days ago
Solventum Third Quarter 2024 Earnings: Beats Expectations
PR Newswire
10 days ago
Solventum Reports Third Quarter 2024 Financial Results and Raises Full-Year Guidance
The Wall Street Journal
24 days ago
Recent 3M Spinoff Eyes Potential Deal
The Wall Street Journal
24 days ago
Recent 3M Spinoff Solventum Explores Sale of Filtration Unit
Investor's Business Daily
a month ago
The Second-Best Dow Jones Stock Of 2024 Whipsawed After Earnings Beat
Argus Research
a month ago
Technical Assessment: Bullish in the Intermediate-Term
Compare SOLV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SOLV SOLVENTUM CORP - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.